Review highlights individualized non-hormonal therapies for symptom treatment A large proportion of the world’s estimated 9.3 million breast cancer survivors experience menopausal symptoms or clinical manifestations of estrogen deficiency. A comprehensive review published in The Journal of Clinical Endocrinology & Metabolism focuses on current and future approaches to management of menopausal symptoms after breast cancer. Menopause...
Researchers have shown that autocrine human prolactin (hPRL) promotes endometrial tumor growth and metastasis, as well as reduces sensitivity to chemotherapy, leading to worse survival outcomes. Based on this association, the investigators also point to a possible therapeutic strategy for endometrial cancer (EC). The results were published recently in Endocrinology. The team, led by Peter...
Children who were exposed to radiation following the Chernobyl nuclear accident in April 1986 may have an increased risk of developing thyroid nodules, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Elizabeth K. Cahoon, SM, MHS, PhD, of the Radiation Epidemiology Branch, DCEG, at the National...
The natural fetal estrogen estetrol, also called E4, is being tested as a new drug that may help treat advanced prostate cancer, according to an ongoing industry-sponsored study from the Netherlands. The final results will be presented in a poster on Saturday, April 1, at ENDO 2017, the annual scientific meeting of the Endocrine Society,...
While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies. In a study published online this month in the journal Clinical Cancer Research, the authors reported that they isolated multiple key gene alterations...
This issue highlights the 8th edition of EBR – a mock-exam with more than 240 clinical case questions. Hear expert commentary and read in-depth answer rationales. Available on the online store. A 34-year-old woman presents with nausea, vomiting, mental confusion, and dehydration. Her history is positive for a Wilms tumor as a child and uterine...
A new study presented at ENDO 2016 revealed a possible link between bisphenol A exposure in utero to breast cancer later in life. In the process, the researchers created a new bioassay that can test chemicals much faster than typical animal studies. Almost every single person alive today has detectable amounts of endocrine-disrupting chemicals (EDCs)...
As survival rates from pancreatic cancer slowly inch upward, a new drug therapy may offer patients a brighter outlook. For many decades, a diagnosis of pancreatic cancer has been associated with a dismal chance of survival. In 2008, the overall five-year relative survival rate climbed above 5% for the first time — reaching a high...
Neoplasia, including both cancers and benign conditions, requires prompt and accurate diagnosis — and treatment — to preserve life and comfort. In the field of endocrinology, neoplasia is a serious concern.
Endocrine neoplasia, whether or not it is cancerous, can throw the entire endocrine system out of balance. So doctors and patients alike need a source for up-to-date information about neoplasia in the endocrine field. Endocrine News has collected all of the articles and information you need about neoplasia, cancer and the endocrine system, and showcased them in one convenient location where both doctors and patients can get the information they need to make informed treatment decisions.
Updated Information About New Treatments and Therapies
On the Neoplasia and Cancer page, you will find articles highlighting promising new therapies and treatments, including pertinent research studies that highlight the effectiveness of these up-and-coming therapies. By staying current with these insights and changes in the field, doctors will be able to offer their patients the best possible solutions for their conditions, and patients will be able to research the top treatment options on their own.
Case Studies in the Neoplasia and Cancer Field
An important part of the resources found on this page is the case studies. By reading real-life case studies relating to cancer and other neoplasia conditions, you will be able to understand the impact of these diseases and their potential treatments on real patients. Case studies also help patients and doctors see what cancer and neoplasia symptoms look like in daily life.
Health Warnings and Advice
The resources on this page provide pertinent health warnings and advice to help patients avoid cancer and tumor risks. By staying informed, both doctors and their patients can help encourage healthier habits to limit the risk of developing neoplasia symptoms and cancer. These warnings and advice articles are specific to endocrine neoplasia conditions.
This issue highlights the 8th edition of EBR – a mock-exam with more than 240 clinical case questions. Hear expert commentary and read in-depth answer rationales. Available on the online store. A 34-year-old woman presents with nausea, vomiting, mental confusion, and dehydration. Her history is positive for a Wilms tumor as a child and uterine...
A new study presented at ENDO 2016 revealed a possible link between bisphenol A exposure in utero to breast cancer later in life. In the process, the researchers created a new bioassay that can test chemicals much faster than typical animal studies. Almost every single person alive today has detectable amounts of endocrine-disrupting chemicals (EDCs)...
As survival rates from pancreatic cancer slowly inch upward, a new drug therapy may offer patients a brighter outlook. For many decades, a diagnosis of pancreatic cancer has been associated with a dismal chance of survival. In 2008, the overall five-year relative survival rate climbed above 5% for the first time — reaching a high...
